Since SARS-CoV-2 infections can reduce ATP6AP1 levels, and ATP6AP1 expression is associated with immune infiltration in BC, SARS-CoV-2 may influence the occurrence, development and prognosis of BC. The gene discussed is ATP6AP1; the disease is breast cancer.